YANIQUE WALKER: Open Payments
NPI 1134846041 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,953 in 137 payments from 17 companies in 2025. Trend: 2023 $3,481 · 2024 $4,268 · 2025 $3,953
Food & beverage: $3,953
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 35 | $810 |
| Janssen Biotech, Inc. | 12 | $615 |
| ABBVIE INC. | 10 | $398 |
| Novartis Pharmaceuticals Corporation | 12 | $304 |
| Mallinckrodt Hospital Products Inc. | 12 | $304 |
| Alexion Pharmaceuticals, Inc. | 7 | $295 |
| UCB, Inc. | 13 | $289 |
| AstraZeneca Pharmaceuticals LP | 9 | $233 |
| GlaxoSmithKline, LLC. | 6 | $206 |
| Aurinia Pharma U.S., Inc. | 5 | $193 |
Products named: TREMFYA, ACTHAR, Bimzelx, COSENTYX, STRENSIQ, SAPHNELO, SKYRIZI, EVENITY.
Industry payments across TX — which companies pay providers there.
